Unraveling the chemotherapeutic potential of taxifolin ruthenium-p-cymene complex in breast carcinoma: Insights into AhR signaling pathway in vitro and in vivo
Translational Oncology · 2024-11 · 49 · 102107
DOI: 10.1016/j.tranon.2024.102107 ↗Kurz gefasst
Fachartikel in der Zeitschrift Translational Oncology, 2024-11. Verfasst von Abhijit Das und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, NSHM Knowledge Campus- Kolkata, 124 BL. Saha Road, Kolkata, West Bengal 700053, India. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacy, NSHM Knowledge Campus- Kolkata, 124 BL. Saha Road, Kolkata, West Bengal 700053, India.
- Department of Pharmacy, NSHM Knowledge Campus- Kolkata, 124 BL. Saha Road, Kolkata, West Bengal 700053, India. Electronic address: souvik.roy@nshm.com.
Zitieren
APA
Das, A., Bhattacharya, B., Gayen, S., & Roy, S. (2024). Unraveling the chemotherapeutic potential of taxifolin ruthenium-p-cymene complex in breast carcinoma: Insights into AhR signaling pathway in vitro and in vivo. Translational Oncology, 49, 102107. https://doi.org/10.1016/j.tranon.2024.102107
Vancouver
Das A, Bhattacharya B, Gayen S, Roy S. Unraveling the chemotherapeutic potential of taxifolin ruthenium-p-cymene complex in breast carcinoma: Insights into AhR signaling pathway in vitro and in vivo. Translational Oncology. 2024;49:102107. doi:10.1016/j.tranon.2024.102107
BibTeX
@article{Das2024,
author = {Das, Abhijit and Bhattacharya, Barshana and Gayen, Sakuntala and Roy, Souvik},
title = {Unraveling the chemotherapeutic potential of taxifolin ruthenium-p-cymene complex in breast carcinoma: Insights into AhR signaling pathway in vitro and in vivo},
journal = {Translational Oncology},
year = {2024},
volume = {49},
pages = {102107},
doi = {10.1016/j.tranon.2024.102107}
}
EUVIMED